Healthcare fund manager ORI Capital has announced the first closing of a healthcare fund with a targeted size of $400 million. The new fund was unveiled just as ORI and its partners entered an agreement to sell their investment in British clinical-stage biopharmaceutical company Kymab in a deal worth up to $1.45 billion with French drugmaker Sanofi.
¬ Haymarket Media Limited. All rights reserved.
